{"name":"Shanghai Argo Biopharmaceutical Co., Ltd.","slug":"shanghai-argo-biopharmaceutical-co-ltd","ticker":"","exchange":"","domain":"shanghaiargobiopharmaceutical.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BW-00112","genericName":"BW-00112","slug":"bw-00112","indication":"Other","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BW-20805","genericName":"BW-20805","slug":"bw-20805","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"BW-00112","genericName":"BW-00112","slug":"bw-00112","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BW-20805","genericName":"BW-20805","slug":"bw-20805","phase":"phase_2","mechanism":"BW-20805 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQblVacUhkbHViTXJnZDNta0Q1OXFROUtKazhjU0pXVWI3ZVppSi11YUJtR3hqRkVpTm5sTF9RM1FQX3kwY1RHTlVjMzJJODdIbTJvakk3NFByaUJuNWN6Z1A3S2M4aG52N2RLRDFqeHRfYVEzdWVaMHhkM0tQYUt2cFNFQ1k1RllCaVdQdDVnQl9PdU5ZcnVYVDZCelZNYW5OVEo2TERUZ2FFUHpwMEFrWEJIdTNvdk14RFNKTWhhNVEyMjZDVDFnVFoyOFdEdTJMZjZWWHIzQlVYeWRmSDhzRmlyNHY0Sml1bHVRc3hOT1ozbFp6MGlBWGxpeXdKZENJSS03Uzhma3puRkljVG9YdTFvTTg?oc=5","date":"2026-02-25","type":"trial","source":"PR Newswire","summary":"Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annual Meeting - PR Newswire","headline":"Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annu","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQMTR3ck1uR2lMWUFjdXZhalZhMUxJNVp5eDdkM05yYkJrXzZDVjdhWjB4c0FOWkY5NjJDS1F5LVp2NGpJbFpkRTByUXk3R0lxek5kZXpQWHFKYkRTb3VNMXNSQ2pVQUdKMm1SWVQwcHNYZWhyQkpYeVpZOWhSaFBEcGd5Y0Jzb1RYTzJLU2xCOTNqcFhmOTBGRHo0bmdLOTA?oc=5","date":"2025-09-09","type":"deal","source":"BioWorld News","summary":"Novartis taps Argo again, inks potential $5.2B collaboration - BioWorld News","headline":"Novartis taps Argo again, inks potential $5.2B collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxONlRxX0laTjlka2d3Mi0yNlFqNF80ZVlVbHF4RnppV294TWRMSWZVQWZkSHlJT1h6anhiMkxqTklpTjFZWXlYazFmbHByY2l4VGpiOGNXMmg2Rm0yWnNBZUJib25JUVhmWGN5X0pRS3pEZUVhSXlhWjRRT1Q2ZnFKeGo1MHJ0Y1k4QldsUkw2aHlNS0Z6V21ZMFVQd3VmY2s3OXdPMzRlTml0NkFGOGNiWmJMU1ZqRkI4MjhzR2NCSGJaZV82Y3QtRFFjMzB1SzV4eERtOVc2OHZ2RlpBcTVtTzNWWUhjd9IB6wFBVV95cUxNOGZyU2t2a0drRUctdlFYQ19qdG1QNTljb3RCR1NRMFFQLVB1RXV1MU1CdWNRYTFGTUhtS3BOQTFhUVNFMlE5SUMtYnkyY0tlZ0VabXZBZFJ3M3pfXzJRRjc0NnJ1UXJXS19GYmJMSy1UR0dKcDlPOEV4d2J4V0w3aUlCSmk4bWUwTTB1LTRWcDhKQTJsbUZPMUhSTFFxS0ZGR01OUGdDa09hZlo2QzBtQUdNM28yMWF5N3JzSjZkdTdUdHJpelFkdjlkdGQ5ZkNNRjlnSUFrVG5aUlg4ME9WMkJOd3V5VXREeXBR?oc=5","date":"2025-09-04","type":"deal","source":"Medical Dialogues","summary":"Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal - Medical Dialogues","headline":"Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNbWFjN0E1bGtzRmkxOEo0alc0ZVNFY010ZDlUVzhmejUtWmxLUjVQemxlVVE2M0lvX25lZmIzdEtSZTZhblJibTBaYWN1UU1lSUlkcXRMVUFmSVhfQy1Rb0hUZUI1OGx5Z3lwekFLeklPMlg4ZV81aldNUDdPdkFhZk9oS2NNMi10NmgzZmd0T2VXRzRqeUlvTjh3Nk1hT3I4cWpsamZnS21sQnRGTkVjbEZvWEhhZFVMdVZsX1BJNXZnaTRiMkV1TmFHazdBOGdPNWJNQmNQMDU0WS1zdjVsSVB1bHNOOWxuRGxzMmZPM2QtNTUzSGpIVkZldEZGVjFuc1pZVHN3Vm11WmN5S2t3ZWtR?oc=5","date":"2025-09-03","type":"deal","source":"PR Newswire","summary":"Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular Diseases - PR Newswire","headline":"Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOS0owQWlKSjFDU21udVROY0J6RTFScW45U0ZCSUV2UVc4VjJtLVBJcnZoRGItZDY5QlhIWFpJVmJMNFJHMXZyTW14czVzVDJOSGdfM3JjbDE4MEE1emRfUEpGdnRlUzNNSnpGenhvbU5CS2tRRDkzWnhRcVh2ekNOTTczQUt4aXA3bUFrN1lxMmtJSFZzRlZ0Uw?oc=5","date":"2025-09-03","type":"pipeline","source":"BioSpace","summary":"Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment - BioSpace","headline":"Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPWEU4ZzBxZUF1LVNUWTQ4NGplVHFDdnlPQ2J2WFVUcEdOcmZzRG5jbHQ2eE9RNjBORGlrWTctQjlia2xpcENvNTFXSWtYWkFDWnNOWWVIeGE3VTgxYy1Dc25ZdFBGRTlSdElLOVB1Uldtei02cDkwWmFJNFhnMUkxMHJaZ1NrT3duenJJWUprYlFLd3JzZkdQdldmY01JR3c?oc=5","date":"2025-09-03","type":"pipeline","source":"Fierce Biotech","summary":"Novartis returns to Argo for multifaceted $5B cardiovascular collab - Fierce Biotech","headline":"Novartis returns to Argo for multifaceted $5B cardiovascular collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNM0NpT3EwaC1KRllnZXY3cFYyTlhpUUMtWFYzc3hXeVBXSkxHR3M0OEtGREYwU1JRUTlSRG1hcWF6VE03aEYyLVRwUkFOSXlfQXVQYUo2TFFjR0lxM3RxNFBPLURBTmowMTgtSzR6MVZ1WXlFMlhpUE5sdlJvcFQ2cDJHU2VjQVVMNVdOaGZMM1BEWHdUT1o4Z0JhNGVNbm02d29jMzZR?oc=5","date":"2025-05-20","type":"deal","source":"BioSpace","summary":"Pfizer’s China Deal Worth up to $6B Eclipses Peers in a Frenzied Market - BioSpace","headline":"Pfizer’s China Deal Worth up to $6B Eclipses Peers in a Frenzied Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOY3pRbVFLSmY2anFwdC1UaFUzcnBsQzBCeXZrS1VuUVcySzE1c2MyU2otMmxsaUxVTDh6aXoyR0hJVnNiVVpUaVNKYU1UZW8tUVlnMjl5WkI0b2c1MHMzSkh2ZGhrWUhENWV3UEhXTjcyQ216WEhrUEs4TUxMZWsxOFdVdw?oc=5","date":"2025-02-05","type":"deal","source":"BioSpace","summary":"The Top 7 Biopharma Licensing Deals of 2024 - BioSpace","headline":"The Top 7 Biopharma Licensing Deals of 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQMDVqemF2SllMZ2Z3NHhzaVY1OGhUUnBaNXFTUE5UbVhXMnlVZnR5ck1yZHozLUUzNGhHaVpCelU0dmlyc0YyYVFWWEhBdlN4NzNPRzgxVnRaSUtfOTV6NmFiRld1UnhCUEI0cnctRFBJYl9ydnZqQjFSVHd3X1ptTGZoRm9VTi1pSElYaHhrcGdhOGlSdFp1c25WcVpsTzRDeFE?oc=5","date":"2024-12-30","type":"pipeline","source":"BioWorld News","summary":"Ausperbio bags $73M series B for hep B-targeting RNA therapy - BioWorld News","headline":"Ausperbio bags $73M series B for hep B-targeting RNA therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQWGNIUlFVakx1ZTEzV01hZXNHbWJVWF8xMmlVcGF2R2JjMzJKWG1jRVdHNHNtNlh3bjg0Z3VFeHljWE9PUk02bVgyMVNPMTJvN2pwWlBNU0dXczh0MFQ0NXZ3cC1NZ1Rsaml3cDFQLVFSRXJ1cjducVlISUZoUjFUOVZZTEJtN2FvLW9EZVEyazB3dDJGNzdIcmVrWmM1d09iaHF0WA?oc=5","date":"2024-07-24","type":"deal","source":"BioWorld News","summary":"With Dren deal, Novartis has three of year’s top collaborations - BioWorld News","headline":"With Dren deal, Novartis has three of year’s top collaborations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMTBycmFDa3VYTWMxaWRmNE5qZTV4YWQzcnh2NHRmVW5kRm44WjhnRk84WnR6QXNIOWk3SG40UTNKbmtyRU1lMTlxTlVILWxOdUQ4UlZDcUlpb01OVVZROXdPaGQ3TmlCUEhrRlFCVk9yaUJWYzlFa3FqaVhnNlVuMndUdUgyWHlxR09zaC1KdjlockNPUmRVczQ5dkNsQ3dTZDFKSg?oc=5","date":"2024-01-09","type":"deal","source":"BioWorld News","summary":"Argo, Novartis sign two deals for CV assets for potentially $4B+ - BioWorld News","headline":"Argo, Novartis sign two deals for CV assets for potentially $4B+","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}